Literature DB >> 18596858

President's address: travel medicine and principles of safe travel.

Herbert L DuPont1.   

Abstract

Persons crossing international boundaries away from their medical support systems are put at risk for illness and injury. Travel medicine is a new medical discipline that quantifies these health risks and develops strategies for reducing them. Obtaining health and evacuation insurance for a future trip is important for persons with medical conditions, those planning trips to developing tropical or semi-tropical regions of the world or when an international stay anywhere will be as long as a month. Pre-travel medical evaluation, vaccines against endemic infectious diseases and medications to reduce the occurrence of diarrhea and malaria during trips to endemic areas, and medications for self-treatment of common illnesses such as diarrhea are fundamental to travel medicine. There are a number of miscellaneous areas to consider in travel medicine including preventing deep vein thrombosis and minimizing jet lag during long haul air travel and reducing the occurrence of accidents and water- and altitude-related illnesses. An important recently defined challenge to the field is the growing number of ill-prepared persons put at great risk for illness while visiting friends and relatives living in areas of reduced hygiene. All persons need to have an idea of how and where they may find medical care if they develop illness while abroad. This article summarizes essential elements in travel medicine and offers 10 recommendations for safe travel.

Entities:  

Mesh:

Year:  2008        PMID: 18596858      PMCID: PMC2394696     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  93 in total

1.  Overseas fatalities of United States citizen travelers: an analysis of deaths related to international travel.

Authors:  S W Hargarten; T D Baker; K Guptill
Journal:  Ann Emerg Med       Date:  1991-06       Impact factor: 5.721

Review 2.  Enteric (typhoid) fever in travelers.

Authors:  Buddha Basnyat; Ashish P Maskey; Mark D Zimmerman; David R Murdoch
Journal:  Clin Infect Dis       Date:  2005-09-28       Impact factor: 9.079

3.  The practice of travel medicine: guidelines by the Infectious Diseases Society of America.

Authors:  David R Hill; Charles D Ericsson; Richard D Pearson; Jay S Keystone; David O Freedman; Phyllis E Kozarsky; Herbert L DuPont; Frank J Bia; Philip R Fischer; Edward T Ryan
Journal:  Clin Infect Dis       Date:  2006-11-08       Impact factor: 9.079

Review 4.  Travel-related vaccines.

Authors:  M E Wilson
Journal:  Infect Dis Clin North Am       Date:  2001-03       Impact factor: 5.982

5.  Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa.

Authors:  R Steffen; E Fuchs; J Schildknecht; U Naef; M Funk; P Schlagenhauf; P Phillips-Howard; C Nevill; D Stürchler
Journal:  Lancet       Date:  1993-05-22       Impact factor: 79.321

6.  Aircraft cabin air recirculation and symptoms of the common cold.

Authors:  Jessica Nutik Zitter; Peter D Mazonson; Dave P Miller; Stephen B Hulley; John R Balmes
Journal:  JAMA       Date:  2002 Jul 24-31       Impact factor: 56.272

7.  Evaluation and management of the cardiovascular patient embarking on air travel.

Authors:  Stephen E Possick; Michèle Barry
Journal:  Ann Intern Med       Date:  2004-07-20       Impact factor: 25.391

8.  Loperamide plus azithromycin more effectively treats travelers' diarrhea in Mexico than azithromycin alone.

Authors:  Charles D Ericsson; Herbert L DuPont; Pablo C Okhuysen; Zhi-Dong Jiang; Margaret W DuPont
Journal:  J Travel Med       Date:  2007 Sep-Oct       Impact factor: 8.490

9.  Incidence and clinical features of traveler's diarrhea in infants and children.

Authors:  B Pitzinger; R Steffen; A Tschopp
Journal:  Pediatr Infect Dis J       Date:  1991-10       Impact factor: 2.129

10.  Malaria risk in travelers.

Authors:  Helena Hervius Askling; Jenny Nilsson; Anders Tegnell; Ragnhild Janzon; Karl Ekdahl
Journal:  Emerg Infect Dis       Date:  2005-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.